English
简体中文
Total: £ 56.28
Published Date: 2026-04-08 | Pages: 94 | Tables: 103 | Pharma & Healthcare
The global Live Herpes Zoster Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Live Herpes Zoster Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Live Herpes Zoster Vaccine refers to a vaccine used to prevent shingles. Shingles is a disease caused by the varicella-zoster virus, which usually reoccurs years after a chickenpox infection. This vaccine is attenuated, using a live virus strain that has been weakened, hence the name attenuated vaccine. Vaccination with the attenuated shingles vaccine can help prevent or reduce episodes of shingles and reduce the risk of complications. (Now all companies have achieved commercial production, except for SIBP CNBG, which is in the Phase II experimental stage.)
The North American market for Live Herpes Zoster Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Live Herpes Zoster Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Live Herpes Zoster Vaccine include Merck, GSK, SK, Changchun BCHT Biotechnology, SIBP CNBG, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Live Herpes Zoster Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Live Herpes Zoster Vaccine. The Live Herpes Zoster Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Live Herpes Zoster Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Live Herpes Zoster Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
GSK
SK
Changchun BCHT Biotechnology
SIBP CNBG
Segment by Type
Single-dose Vaccination
Double-dose Vaccination
by Application
Public Health Sector
Hospitals & clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Live Herpes Zoster Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Live Herpes Zoster Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Live Herpes Zoster Vaccine Market Overview
1.1 Product Definition
1.2 Live Herpes Zoster Vaccine by Type
1.2.1 Global Live Herpes Zoster Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Single-dose Vaccination
1.2.3 Double-dose Vaccination
1.3 Live Herpes Zoster Vaccine by Application
1.3.1 Global Live Herpes Zoster Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Public Health Sector
1.3.3 Hospitals & clinics
1.3.4 Others
1.4 Global Live Herpes Zoster Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live Herpes Zoster Vaccine Revenue 2021–2032
1.4.2 Global Live Herpes Zoster Vaccine Sales 2021–2032
1.4.3 Global Live Herpes Zoster Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Live Herpes Zoster Vaccine Market Competition by Manufacturers
2.1 Global Live Herpes Zoster Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Live Herpes Zoster Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Live Herpes Zoster Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Live Herpes Zoster Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Live Herpes Zoster Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Live Herpes Zoster Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Live Herpes Zoster Vaccine, Date of Entry into the Industry
2.8 Global Live Herpes Zoster Vaccine Market Competitive Situation and Trends
2.8.1 Global Live Herpes Zoster Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Live Herpes Zoster Vaccine Players Market Share by Revenue
2.8.3 Global Live Herpes Zoster Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Herpes Zoster Vaccine Market Scenario by Region
3.1 Global Live Herpes Zoster Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Live Herpes Zoster Vaccine Sales by Region: 2021–2032
3.2.1 Global Live Herpes Zoster Vaccine Sales by Region: 2021–2026
3.2.2 Global Live Herpes Zoster Vaccine Sales by Region: 2027–2032
3.3 Global Live Herpes Zoster Vaccine Revenue by Region: 2021–2032
3.3.1 Global Live Herpes Zoster Vaccine Revenue by Region: 2021–2026
3.3.2 Global Live Herpes Zoster Vaccine Revenue by Region: 2027–2032
3.4 North America Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.4.1 North America Live Herpes Zoster Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Live Herpes Zoster Vaccine Sales by Country (2021–2032)
3.4.3 North America Live Herpes Zoster Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.5.1 Europe Live Herpes Zoster Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Live Herpes Zoster Vaccine Sales by Country (2021–2032)
3.5.3 Europe Live Herpes Zoster Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Herpes Zoster Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live Herpes Zoster Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Live Herpes Zoster Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live Herpes Zoster Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Live Herpes Zoster Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Live Herpes Zoster Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Herpes Zoster Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Herpes Zoster Vaccine Sales by Type (2021–2032)
4.1.1 Global Live Herpes Zoster Vaccine Sales by Type (2021–2026)
4.1.2 Global Live Herpes Zoster Vaccine Sales by Type (2027–2032)
4.1.3 Global Live Herpes Zoster Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Live Herpes Zoster Vaccine Revenue by Type (2021–2032)
4.2.1 Global Live Herpes Zoster Vaccine Revenue by Type (2021–2026)
4.2.2 Global Live Herpes Zoster Vaccine Revenue by Type (2027–2032)
4.2.3 Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Live Herpes Zoster Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Live Herpes Zoster Vaccine Sales by Application (2021–2032)
5.1.1 Global Live Herpes Zoster Vaccine Sales by Application (2021–2026)
5.1.2 Global Live Herpes Zoster Vaccine Sales by Application (2027–2032)
5.1.3 Global Live Herpes Zoster Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Live Herpes Zoster Vaccine Revenue by Application (2021–2032)
5.2.1 Global Live Herpes Zoster Vaccine Revenue by Application (2021–2026)
5.2.2 Global Live Herpes Zoster Vaccine Revenue by Application (2027–2032)
5.2.3 Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Live Herpes Zoster Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Live Herpes Zoster Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Live Herpes Zoster Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Live Herpes Zoster Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Live Herpes Zoster Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 SK
6.3.1 SK Company Information
6.3.2 SK Description and Business Overview
6.3.3 SK Live Herpes Zoster Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SK Live Herpes Zoster Vaccine Product Portfolio
6.3.5 SK Recent Developments/Updates
6.4 Changchun BCHT Biotechnology
6.4.1 Changchun BCHT Biotechnology Company Information
6.4.2 Changchun BCHT Biotechnology Description and Business Overview
6.4.3 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolio
6.4.5 Changchun BCHT Biotechnology Recent Developments/Updates
6.5 SIBP CNBG
6.5.1 SIBP CNBG Company Information
6.5.2 SIBP CNBG Description and Business Overview
6.5.3 SIBP CNBG Live Herpes Zoster Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 SIBP CNBG Live Herpes Zoster Vaccine Product Portfolio
6.5.5 SIBP CNBG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Herpes Zoster Vaccine Industry Chain Analysis
7.2 Live Herpes Zoster Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Herpes Zoster Vaccine Production Mode & Process Analysis
7.4 Live Herpes Zoster Vaccine Sales and Marketing
7.4.1 Live Herpes Zoster Vaccine Sales Channels
7.4.2 Live Herpes Zoster Vaccine Distributors
7.5 Live Herpes Zoster Vaccine Customer Analysis
8 Live Herpes Zoster Vaccine Market Dynamics
8.1 Live Herpes Zoster Vaccine Industry Trends
8.2 Live Herpes Zoster Vaccine Market Drivers
8.3 Live Herpes Zoster Vaccine Market Challenges
8.4 Live Herpes Zoster Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Live Herpes Zoster Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Live Herpes Zoster Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Live Herpes Zoster Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Live Herpes Zoster Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Live Herpes Zoster Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Live Herpes Zoster Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Live Herpes Zoster Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Live Herpes Zoster Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Live Herpes Zoster Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Live Herpes Zoster Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Live Herpes Zoster Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Live Herpes Zoster Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Live Herpes Zoster Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Live Herpes Zoster Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Live Herpes Zoster Vaccine Sales by Region (K Dose), 2021–2026
Table 18. Global Live Herpes Zoster Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Live Herpes Zoster Vaccine Sales by Region (K Dose), 2027–2032
Table 20. Global Live Herpes Zoster Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Live Herpes Zoster Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Live Herpes Zoster Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Live Herpes Zoster Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Live Herpes Zoster Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Live Herpes Zoster Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Live Herpes Zoster Vaccine Sales by Country (K Dose), 2021–2026
Table 27. North America Live Herpes Zoster Vaccine Sales by Country (K Dose), 2027–2032
Table 28. North America Live Herpes Zoster Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Live Herpes Zoster Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Live Herpes Zoster Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Live Herpes Zoster Vaccine Sales by Country (K Dose), 2021–2026
Table 32. Europe Live Herpes Zoster Vaccine Sales by Country (K Dose), 2027–2032
Table 33. Europe Live Herpes Zoster Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Live Herpes Zoster Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Live Herpes Zoster Vaccine Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Live Herpes Zoster Vaccine Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Live Herpes Zoster Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Live Herpes Zoster Vaccine Sales by Country (K Dose), 2021–2026
Table 42. Latin America Live Herpes Zoster Vaccine Sales by Country (K Dose), 2027–2032
Table 43. Latin America Live Herpes Zoster Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Live Herpes Zoster Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Live Herpes Zoster Vaccine Sales (K Dose) by Type (2021–2026)
Table 51. Global Live Herpes Zoster Vaccine Sales (K Dose) by Type (2027–2032)
Table 52. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2021–2026)
Table 59. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2027–2032)
Table 60. Global Live Herpes Zoster Vaccine Sales (K Dose) by Application (2021–2026)
Table 61. Global Live Herpes Zoster Vaccine Sales (K Dose) by Application (2027–2032)
Table 62. Global Live Herpes Zoster Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Live Herpes Zoster Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2021–2026)
Table 69. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Merck Live Herpes Zoster Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. GSK Live Herpes Zoster Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. SK Company Information
Table 81. SK Description and Business Overview
Table 82. SK Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. SK Live Herpes Zoster Vaccine Product
Table 84. SK Recent Developments/Updates
Table 85. Changchun BCHT Biotechnology Company Information
Table 86. Changchun BCHT Biotechnology Description and Business Overview
Table 87. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product
Table 89. Changchun BCHT Biotechnology Recent Developments/Updates
Table 90. SIBP CNBG Company Information
Table 91. SIBP CNBG Description and Business Overview
Table 92. SIBP CNBG Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. SIBP CNBG Live Herpes Zoster Vaccine Product
Table 94. SIBP CNBG Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Live Herpes Zoster Vaccine Distributors List
Table 98. Live Herpes Zoster Vaccine Customers List
Table 99. Live Herpes Zoster Vaccine Market Trends
Table 100. Live Herpes Zoster Vaccine Market Drivers
Table 101. Live Herpes Zoster Vaccine Market Challenges
Table 102. Live Herpes Zoster Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Live Herpes Zoster Vaccine
Figure 2. Global Live Herpes Zoster Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Live Herpes Zoster Vaccine Market Share by Type: 2025 & 2032
Figure 4. Single-dose Vaccination Product Picture
Figure 5. Double-dose Vaccination Product Picture
Figure 6. Global Live Herpes Zoster Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Live Herpes Zoster Vaccine Market Share by Application: 2025 & 2032
Figure 8. Public Health Sector
Figure 9. Hospitals & clinics
Figure 10. Others
Figure 11. Global Live Herpes Zoster Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Live Herpes Zoster Vaccine Market Size (US$ Million), 2021–2032
Figure 13. Global Live Herpes Zoster Vaccine Sales (K Dose), 2021–2032
Figure 14. Global Live Herpes Zoster Vaccine Average Price (US$/Dose), 2021–2032
Figure 15. Live Herpes Zoster Vaccine Report Years Considered
Figure 16. Live Herpes Zoster Vaccine Sales Share by Manufacturers in 2025
Figure 17. Global Live Herpes Zoster Vaccine Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Live Herpes Zoster Vaccine Players: Market Share by Revenue in Live Herpes Zoster Vaccine in 2025
Figure 19. Live Herpes Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Live Herpes Zoster Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Live Herpes Zoster Vaccine Sales Market Share by Country (2021–2032)
Figure 22. North America Live Herpes Zoster Vaccine Revenue Market Share by Country (2021–2032)
Figure 23. United States Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Live Herpes Zoster Vaccine Sales Market Share by Country (2021–2032)
Figure 26. Europe Live Herpes Zoster Vaccine Revenue Market Share by Country (2021–2032)
Figure 27. Germany Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Live Herpes Zoster Vaccine Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Live Herpes Zoster Vaccine Revenue Market Share by Region (2021–2032)
Figure 34. China Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Live Herpes Zoster Vaccine Sales Market Share by Country (2021–2032)
Figure 42. Latin America Live Herpes Zoster Vaccine Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Live Herpes Zoster Vaccine Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Live Herpes Zoster Vaccine Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Live Herpes Zoster Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Live Herpes Zoster Vaccine by Type (2021–2032)
Figure 53. Global Revenue Market Share of Live Herpes Zoster Vaccine by Type (2021–2032)
Figure 54. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2021–2032)
Figure 55. Global Sales Market Share of Live Herpes Zoster Vaccine by Application (2021–2032)
Figure 56. Global Revenue Market Share of Live Herpes Zoster Vaccine by Application (2021–2032)
Figure 57. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2021–2032)
Figure 58. Live Herpes Zoster Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
